[Prevalence of antiphospholipid antibodies in Horton's disease and in polymyalgia rheumatica]. / Prévalence des anticorps antiphospholipides dans la maladie de Horton et dans la pseudo-polyarthrite rhizomélique.

PURPOSE: Antiphospholipid antibodies (APL) are frequently observed in the course of giant cell arteritis and polymyalgia rheumatica. However, their role and relationships with potential ischemic events are still debated. METHODS: To determine the prevalence of APL in relation with ischemic events, 62 patients with giant cell arteritis and/or polymyalgia rheumatica were retrospectively studied. RESULTS: Before corticosteroid treatment 41% of the 51 patients with giant cell arteritis and 64% of the 11 patients with isolated polymyalgic rheumatica had high IgG ACL levels, with a frequency significantly higher than that (15.6%) of the control group which was composed of healthy elderly. IgM ACL were found in only two patients with giant cell arteritis. There was no correlation between the occurrence of an ischemic event (22 ischemic events in the 51 patients with giant cell arteritis) and the presence of ACL, even though the latter were more frequently observed in the giant cell arteritis group (52% versus 41% in non ischemic patients). The prevalence of ACL increased, reaching 59% if lupus anticoagulant was associated, but the difference was not significant. ACL disappeared soon after corticosteroid therapy had been initiated. CONCLUSION: Though ACL are frequently seen in giant cell arteritis and/or polymyalgia rheumatica, they are not related to ischemic events and disappear rapidly after corticosteroid treatment.

Elastase derived elastin peptides: putative autoimmune targets in giant cell arteritis.

OBJECTIVE: Histological analysis of giant cell arteritis (GCA) reveals a granulomatous reaction around the internal elastic lamina. Elastolysis by multinucleated giant cells has also been reported. We investigated elastin derived peptides as putative recall antigens for peripheral blood mononuclear cells (PBMC) from patients with GCA. METHODS: PBMC were collected from 17 patients with GCA (Group 1), 17 patients with vascular diseases, connective tissue diseases, or polymyalgia rheumatica without GCA (Group 2), and 17 healthy controls (Group 3). Cultures of PBMC with different elastin derived peptides or elastase were analyzed. RESULTS: A proliferative response was obtained only with elastate derived elastin peptides in 12/13 untreated patients with GCA. Steroid treatment was believed to abolish this proliferative response in 4 patients with GCA. PBMC from only 3/34 non-GCA subjects responded to these antigens. No proliferative response was obtained for other elastin derived peptides or elastase in any subject. CONCLUSION: Degradation of native elastin by leukocyte elastase can provide elastin derived peptides that act as autoimmune targets for T cells in GCA.

Early expression of E-selectin, tumor necrosis factor alpha, and mast cell infiltration in the salivary glands of patients with systemic sclerosis.

OBJECTIVE: To assess the predictive value of early endothelial E-selectin and tumor necrosis factor alpha (TNF alpha) expression, as well as mast cell infiltration, in the subsequent progression to systemic sclerosis (SSc) in patients with Raynaud's phenomenon (RP) and abnormal nailfold capillaroscopic findings. METHODS: Clinical criteria were evaluated, and immunostaining was performed on lip biopsy samples from 22 patients with RP and abnormal capillaroscopic results. None of these patients initially fulfilled the American College of Rheumatology criteria for SSc. RESULTS: E-selectin, TNF alpha, and mast cell infiltration were found in 9, 10, and 8 of 11 patients, respectively, whose disease progressed to SSc, and in 0, 2, and 1 of 11 patients, respectively, whose disease did not progress to SSc (P < 0.001, P < 0.01, and P < 0.01, respectively). CONCLUSION: E-selectin, TNF alpha, and mast cell infiltration are detectable in the very early stages of SSc, prior to the onset of skin changes.

[Initial manifestations and late diagnosis in chronic atrophic polychondritis: apropos of a series of 15 patients]. / Manifestations révélatrices et retard diagnostique dans la polychondrite chronique atrophiante: à propos d'une série de 15 malades.

An auricular or nasal chondritis or a saddle nose deformity are the initial manifestation in half of cases of relapsing polychondritis; the other initial manifestations are various and less evocative; polyarthritis, laryngo-tracheal symptoms, episcleritis which delay the diagnosis. From 15 cases of relapsing polychondritis, the diagnosis time from the first symptom are studied; this one is long, about 3 years and 6 months (from 3 months to 17 years) in 13/15 of the cases even if the first manifestation is typical (external chondritis). In two cases only, the diagnosis was established after the first attack. This late of diagnosis had socioeconomical impact and exposed to severe complications like tracheal chondritis.

[Testicular localization of systemic diseases]. / Localisation testiculaire des maladies systémiques.

Acute orchitis or a mass in testis usually evokes a neoplasm, a torsion or infectious disease for the clinician. Rarely, a systemic disease is involved. Nevertheless, testicular involvement occurs during vasculitis, Behçet or granulomatous diseases, but is uncommonly the first manifestation. Histologic changes after biopsy or orchiectomy usually give the diagnosis. Testicular localization of systemic disease does not change the general treatment.

[Variations and valve structure of the truncal femoro-popliteal system]. / Variations et valvulation du système tronculaire fémoro-poplité.

Study of valves is inseparable from that of the main veins in which they are located. While a modal femoro-popliteal system, satellite to the arterial system, is by far the commonest, major variations are seen in approximately 10% of cases. Each main collecting vein has its specificity, according to its width, the course which it follows and whether or not there is a satellite wide calibre artery. Additional features include the chief affluents which its receives, wavering of its course, the supple or rigid perivascular environment and the proximity of large muscle masses. All these features play a role in the quality of drainage, in particular during exercise, and in anti-reflux function. In practice, variations come down to two broad possibilities: the single collector, sometimes made up of several different embryological segments, resulting in a hybrid vessel and an aberrant course, either axial, satellite to the sciatic nerve, or profunda femoris, satellite to the shaft of the femur. Doubling (bifid or by bifurcation) opens up an additional channel, either parallel or divergent, which considerably modifies the conditions of venous return. A lesion affecting one branch only, e.g. a solitary thrombus, may have no clinical manifestations and marking if collectors during imaging. The topography of the valves of the main veins tends to be fairly fixed. They are preferentially located proximal to the main confluents, to winding parts of the course of the vessel, or at certain hemodynamic levels which vary little from one individual to another. An attempt is made at nomenclature, classification and topography. The chief feature, the terminal valve of the lower limb, is located most often at the femoral ring. It alone is capable of opposing the long cavo-iliac reflux caused by effort. Analysis of retrograde phlebography films with caval occlusion shows that reflux is not directly exerted on the valve. The point of interruption is high, in the terminal portion of the external iliac vein. This hemodynamic barrage is purely functional. When there is incontinence of the terminal valve varying degrees of reflux diffusely affect the femoral axis. At the same time, there is regurgitation of contrast medium into the visceral areas of the true pelvis, normally sealed off. This coupling between anti-reflux function of the lim and that of the pelvis is one of the unexpected aspects of valve activity.